PatientsVille.com Logo

PatientsVille

Quadramet Side Effects

Common Quadramet Side Effects

The most commonly reported Quadramet side effects (click to view or check a box to report):

Pain (15)
Thrombocytopenia (13)
Condition Aggravated (12)
Disease Progression (12)
Nausea (9)
Back Pain (8)
Blood Creatinine Increased (7)
Malignant Neoplasm Progression (7)
Haemoglobin Decreased (7)
Arthralgia (6)
Atrial Fibrillation (6)
Haematuria (6)
Dyspnoea (6)
Anorexia (5)
Acute Pulmonary Oedema (5)
Pain In Extremity (5)
Pancytopenia (5)
Platelet Count Decreased (5)
Anxiety (5)
Cardiac Failure Congestive (4)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Quadramet Side Effects Reported to FDA

The following Quadramet reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Quadramet on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Cardiac Arrest
on Jul 18, 2013 Male from US , 58 years of age, weighting 136.2 lb, was diagnosed with and was treated with Quadramet. Directly after, patient experienced the unwanted or unexpected Quadramet side effects: cardiac arrest. Quadramet dosage: (124 Mci (124 Mci).

Platelet Count Decreased, Neutrophil Count Decreased
Patient was taking Quadramet. Patient felt the following Quadramet side effects: platelet count decreased, neutrophil count decreased on Mar 22, 2013 from US Additional patient health information: Male , 66 years of age, weighting 140.2 lb, was diagnosed with and. Quadramet dosage: N/A.

Thrombocytopenia, Prostate Cancer
Adverse event was reported on Oct 16, 2012 by a Male taking Quadramet (Dosage: 1.5 Gy X2, Intravenous (not Otherwise Specified)) was diagnosed with and. Location: AU , 64 years of age, After Quadramet was administered, patient encountered several Quadramet side effects: thrombocytopenia, prostate cancer.

Thrombocytopenia, Prostate Cancer
on Oct 16, 2012 Male from AU , 71 years of age, was diagnosed with and was treated with Quadramet. Directly after, patient experienced the unwanted or unexpected Quadramet side effects: thrombocytopenia, prostate cancer. Quadramet dosage: 1.5 Gy X 2 , Intravenous (not Otherwise Specified).


Thrombocytopenia
on Oct 16, 2012 Male from US , 69 years of age, was diagnosed with and was treated with Quadramet. Patient felt the following Quadramet side effects: thrombocytopenia. Quadramet dosage: N/A.

Pancytopenia, Neoplasm Progression, Bone Sarcoma
Patient was taking Quadramet. After Quadramet was administered, patient encountered several Quadramet side effects: pancytopenia, neoplasm progression, bone sarcoma on Dec 09, 2010 from Additional patient health information: Female , 19 years of age, was diagnosed with and. Quadramet dosage: 37 To 51.8 Mbq/kg (1.0-1.4 Mci/kg).
Multiple concurrent drugs taken:
  • 18f-fdg (fludeoxyglucose)
  • Contrast Media (contrast Media)


Pancytopenia, Bone Sarcoma, Neoplasm Progression
Adverse event was reported on Dec 09, 2010 by a Female taking Quadramet (Dosage: 37 To 51.8 Mbq/kg (1.0-1.4 Mci/kg)) was diagnosed with and. Location: , 14 years of age, Directly after, patient experienced the unwanted or unexpected Quadramet side effects: pancytopenia, bone sarcoma, neoplasm progression.
Associated medications used:
  • Contrast Media (contrast Media)
  • 18f-fdg (fludeoxyglucose (18f))


Bone Sarcoma, Disease Progression, Pancytopenia
on Dec 09, 2010 Male from , 17 years of age, was diagnosed with and was treated with Quadramet. Patient felt the following Quadramet side effects: bone sarcoma, disease progression, pancytopenia. Quadramet dosage: 37 To 51.8 Mbq/kg (1.0-1.4 Mci/kg).
Multiple prescriptions taken:
  • 18f-fdg (fludeoxyglucose (18f))
  • Contrast Media (contrast Media)


Pleural Effusion, Dyspnoea, Disease Progression, Pancytopenia
on Dec 09, 2010 Female from , 30 years of age, weighting 114.6 lb, was treated with Quadramet. After Quadramet was administered, patient encountered several Quadramet side effects: pleural effusion, dyspnoea, disease progression, pancytopenia. Quadramet dosage: 1.2 Mci/kg, Intravenous.
Multiple concurrent drugs taken:
  • 18f-fdg (fludeoxyglucose (18f))
  • Contrast Media (contrast Media)


Thrombocytopenia, Renal Failure Acute, Femur Fracture, Malaise, Fatigue, Obstruction
Patient was taking Quadramet. Directly after, patient experienced the unwanted or unexpected Quadramet side effects: thrombocytopenia, renal failure acute, femur fracture, malaise, fatigue, obstruction on Feb 15, 2011 from UNITED STATES Additional patient health information: Male , weighting 184.1 lb, . Quadramet dosage: 86.9 Mci.
Associated medications used:
  • Lotrel
  • Vitamin D (400 Iu)
  • Calcium Carbonate (600 Mg)
  • Zometa (4 Mg)
  • Simvastatin
  • Levothroid
  • Aspirin
Patient was hospitalized.

Malignant Neoplasm Progression, Osteosarcoma Metastatic, Pancytopenia
Adverse event was reported on Dec 09, 2010 by a Female taking Quadramet (samarium (153 Gm) Lexidronam) (Dosage: 37 To 51.8 Mbq/kg (1.0-1.4 Mci/kg)) was diagnosed with and. Location: UNITED STATES , 18 years of age, Patient felt the following Quadramet side effects: malignant neoplasm progression, osteosarcoma metastatic, pancytopenia.
Multiple prescriptions taken:
  • 18f-fdg (fludeoxyglucose (18f))
  • Contrast Media(contrast Media)


Metastases To Central Nervous System
on Dec 29, 2010 Female from UNITED STATES , weighting 96.41 lb, was treated with Quadramet. After Quadramet was administered, patient encountered several Quadramet side effects: metastases to central nervous system. Quadramet dosage: .94 Ml.
Multiple concurrent drugs taken:
  • Zometa (4 Mg)
  • Vitamin D2 (3600 Million Iu)
Patient was hospitalized.

Metastases To Central Nervous System
on Dec 28, 2010 Female from UNITED STATES , weighting 96.41 lb, was treated with Quadramet. Directly after, patient experienced the unwanted or unexpected Quadramet side effects: metastases to central nervous system. Quadramet dosage: .94 Ml.
Associated medications used:
  • Zometa (4 Mg)
  • Vitamin D2 (3600 Million Iu)
Patient was hospitalized.

Pneumonia
Patient was taking Quadramet. Patient felt the following Quadramet side effects: pneumonia on Oct 25, 2010 from UNITED STATES Additional patient health information: Female , 62 years of age, weighting 110.2 lb, was diagnosed with and. Quadramet dosage: 50 Mci At A Dose Of 1 Mcg/kg, Intravenous.
Multiple prescriptions taken:
  • Docusate (docusate)
  • Zoledronic Acid


Atelectasis, Culture Urine Positive, Diarrhoea, Pyrexia, White Blood Cell Count Decreased
Adverse event was reported on Mar 11, 2010 by a Male taking Quadramet (Dosage: 1.0 Mci/kg, Intravenous) was diagnosed with and. Location: UNITED STATES , 74 years of age, weighting 211.2 lb, After Quadramet was administered, patient encountered several Quadramet side effects: atelectasis, culture urine positive, diarrhoea, pyrexia, white blood cell count decreased.
Multiple concurrent drugs taken:
  • Docetaxel (3.5714 Mg/m2, 1 In 3 Weeks, Intravenous)
  • Zoledronic Acid
  • Lupron
  • Decadron
  • Prednisone Tab
  • Oxycodone Hcl
  • Meloxicam
  • Ibuprofen
Patient was hospitalized.

Activities Of Daily Living Impaired, Blood Creatine Increased, Blood Glucose Increased, Carbohydrate Antigen 27.29 Increased, Eosinophil Percentage Increased, Haematocrit Decreased, Haemoglobin Decreased, Lymphocyte Percentage Decreased
on Jan 28, 2010 Female from UNITED STATES , 57 years of age, weighting 173.0 lb, was diagnosed with and was treated with Quadramet. Directly after, patient experienced the unwanted or unexpected Quadramet side effects: activities of daily living impaired, blood creatine increased, blood glucose increased, carbohydrate antigen 27.29 increased, eosinophil percentage increased, haematocrit decreased, haemoglobin decreased, lymphocyte percentage decreased. Quadramet dosage: Intravenous.
Associated medications used:
  • Cymbalta (Enteric Coated, 1 Po Bid, Oral)
  • Lorazepam (1 Po Q4h Prn, Oral)
  • Morphine Sulfate (10 Mg/5 Ml; 15 Ml Po Q2-4h Prn, Oral)
  • Morphine Sulfate (Sustained Action, 1 Po O12h, Oral)
  • Ambien Cr, Po Solid Sr (zolpidem Tartrate) (tablets)
  • Azor, Po Solid (amlodipine) (tablets)
  • Caltrate 600+d Plus, Po Solid (calcite D) (tablets)
  • Femara, Po Solid (letrozole) (tablets)


Blood Creatinine Increased, Blood Glucose Increased, Carbohydrate Antigen 27.29 Increased, Eosinophil Percentage Increased, Haemoglobin Decreased, Lymphocyte Percentage Decreased, Mean Platelet Volume Decreased
on Feb 05, 2010 Female from UNITED STATES , 57 years of age, weighting 173.0 lb, was diagnosed with and was treated with Quadramet. Patient felt the following Quadramet side effects: blood creatinine increased, blood glucose increased, carbohydrate antigen 27.29 increased, eosinophil percentage increased, haemoglobin decreased, lymphocyte percentage decreased, mean platelet volume decreased. Quadramet dosage: Intravenous.
Multiple prescriptions taken:
  • Cymbalta (Enteric Coated, 1 Po Bid, Oral)
  • Lorazepam (1 Po Q4h Prn, Oral)
  • Morphine Sulfate (10 Mg/5 Ml; 15 Ml Po Q2-4h Prn, Oral)
  • Morphine Sul Hyt (Sustained Action, 1 Po Q12h, Oral)
  • Ambien Cr, Po Solid Sr (zolpidem Tartrate)(tablets)
  • Azor, Po Solid (amlodipine)(tablets)
  • Caltrate 600+d Plus, Po Solid (calcite D)(tablets)
  • Femara, Po Solid (letrozole) (tablets)


Platelet Count Decreased
Patient was taking Quadramet. After Quadramet was administered, patient encountered several Quadramet side effects: platelet count decreased on Nov 12, 2008 from UNITED STATES Additional patient health information: Male , 56 years of age, weighting 149.0 lb, was diagnosed with and. Quadramet dosage: 135 Mci Iv Injection.
Multiple concurrent drugs taken:
  • ..
  • Zoladex
  • Casodex


Bloody Discharge, Body Temperature Increased, Disease Progression, Hydronephrosis, Hypotension, Lung Disorder, Lymphadenopathy, Mediastinal Disorder, Neutropenia
Adverse event was reported on Sep 09, 2008 by a Male taking Quadramet (Dosage: 99.7 Mci) . Location: UNITED STATES , weighting 190.0 lb, Directly after, patient experienced the unwanted or unexpected Quadramet side effects: bloody discharge, body temperature increased, disease progression, hydronephrosis, hypotension, lung disorder, lymphadenopathy, mediastinal disorder, neutropenia.
Associated medications used:
  • Zometa (25.3 Mg)
  • Lupron + Casodex
  • Mitoxantrone + Prednisone
Patient was hospitalized.

No Adverse Event
on Jan 28, 2008 Male from UNITED STATES , 65 years of age, was diagnosed with and was treated with Quadramet. Patient felt the following Quadramet side effects: no adverse event. Quadramet dosage: N/A.

Asthenia, Dyskinesia, Toxic Encephalopathy
on Jun 06, 2008 Male from UNITED STATES , 70 years of age, was diagnosed with and was treated with Quadramet. After Quadramet was administered, patient encountered several Quadramet side effects: asthenia, dyskinesia, toxic encephalopathy. Quadramet dosage: N/A. Patient was hospitalized.

Dehydration, Duodenal Ulcer, Obstruction Gastric, Reflux Oesophagitis, Urinary Tract Infection
Patient was taking Quadramet. Directly after, patient experienced the unwanted or unexpected Quadramet side effects: dehydration, duodenal ulcer, obstruction gastric, reflux oesophagitis, urinary tract infection on Dec 04, 2007 from UNITED STATES Additional patient health information: Male , weighting 132.3 lb, . Quadramet dosage: Received Only One Dose Per The Protocol On 6/27/2007.
Associated medications used:
  • Vitamin D (2800 Iu Took 2800 Iu Total For This Course (400iu Per Day) But Started In May Of 2007 With Course 1)
  • Zometa (4 Mg)
Patient was hospitalized.

Syncope
Adverse event was reported on Oct 09, 2007 by a Female taking Quadramet (Dosage: 69.5 Mg) . Location: UNITED STATES , weighting 141.3 lb, Patient felt the following Quadramet side effects: syncope.
Multiple prescriptions taken:
  • Zometa (4 Mg)
  • Calcium
  • Vitamin D
  • Levothyroxine Sodium
Patient was hospitalized.

Agitation, Burning Sensation, Dermatitis Allergic
on Jan 09, 2007 Female from UNITED STATES , 57 years of age, weighting 99.21 lb, was diagnosed with and was treated with Quadramet. After Quadramet was administered, patient encountered several Quadramet side effects: agitation, burning sensation, dermatitis allergic. Quadramet dosage: 176 Gbq.
Multiple concurrent drugs taken:
  • Morphine
  • Neurontin
  • Nexiam (esomeprazole)
  • Voltaren
  • Serotonin Antagonists
Patient was hospitalized.

Metastases To Abdominal Cavity, Pain, Thrombocytopenia
on Dec 06, 2006 Male from UNITED STATES , 78 years of age, was diagnosed with and was treated with Quadramet. Directly after, patient experienced the unwanted or unexpected Quadramet side effects: metastases to abdominal cavity, pain, thrombocytopenia. Quadramet dosage: 1 Mci/kg, 37mbq/kg 1 Dose, Intravenous.
Associated medications used:
  • Technetium Tc 99m Methylene Diphosphonate


1 of 4 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Quadramet Side Effects

    Did You Have a Quadramet Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Quadramet for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    Alternative QUADRAMET Names:SAMARIUM

    Active Ingredient: SAMARIUM

    Quadramet Dosage, Warnings, Usage.

    Side Effects reported to FDA: 80

    Quadramet safety alerts: No

    Reported deaths: 23

    Reported hospitalizations: 69

    Latest Quadramet clinical trials

    Quadramet Reviews

    No reviews, be a first to report a side effect via side effect reporting form